SerbinCreative

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK
AtEdge

AtEdge

Photography & Motion
Directory of Illustration

Directory of Illustration

Find the world's best illustrators
PLAY! Illustration

PLAY!

Illustration for Toys & Interactive Games
Lattis Social

Lattis Social

Social Media for the Creative Industry

More from Serbin

Jackie Heda

Alvocidib 

Prev Next
Previous

Lewy Body Dementia and Alzheimer's

medical illustration of Alvocidib is an investigational, intravenously administered. small molecule cyclin-dependent kinase (CDK9) inhibitor. Inhibiting CDK9 is thought to down regulate the transcription of target genes, including myeloid cell leukemia 1 (MCL-1), reducing leukemic blast vitality in MCL-1-dependent hematologic malignancies. #alvocidib #cancer therapy #molecules #apoptosis #leukemia
Next medical illustration of DSP-7888 is an investigational cancer vaccine containing two peptides that induce WT1-specific cytotoxic T lymphocytes and helper cells to attack WT1-expressing cancerous cells found in various types of hematologic malignancies and solid tumors. Researchers have found that adding helper T-cell-inducing peptides, improved outcomes may be achieved compared with a treatment regimen that induced only WT1-CTL's. #cancer therapy DSP-7888 #cancer cell apotheosis #T- cell #cytotoxic lymphoma

Cancer Therapy: DSP-7888

Alvocidib is an investigational, intravenously administered. small molecule cyclin-dependent kinase (CDK9) inhibitor. Inhibiting CDK9 is thought to down regulate the transcription of target genes, including myeloid cell leukemia 1 (MCL-1), reducing leukemic blast vitality in MCL-1-dependent hematologic malignancies. #alvocidib #cancer therapy #molecules #apoptosis #leukemia

Keywords: 3D, Advertising / Marketing, Education, Genetics, Oncology, Mechanism of Action (MOA), Health & Wellness

© Jackie Heda